Skip to main content
Search

# Radiomics

8 related articles

Subscribe to updates
  1. Alzheimer's diagnosis moves to two brain graphs: AD versus CN accuracy rises from 82.06% to 89.90%

    Structural MRI brain graphs no longer rely on a single predefined connection rule. MVMGNN treats brain regions as nodes carrying radiomics features, builds a spatial-neighbor graph and a feature-similarity graph, filters redundant features and weak connections inside each view with a joint node-edge mask, and fuses the two views through patient-level gated fusion. On the ADNI cohort, AD versus CN accuracy rises from 82.06% for the best comparison method, RSEA-MVGNN, to 89.90%, and F1 from 75.02% to 86.24%; gains on the harder AD-MCI and CN-MCI tasks are smaller.

  2. Two-center PCD-CT spectral radiomics in 378 patients: VNC-trained model separates benign from malignant liver lesions at AUC 0.899, with high-keV and VNC test reconstructions most stable

    In a two-center study of 378 patients with focal hepatic lesions (190 benign, 227 lesions; 188 malignant, 2681 lesions), radiomic features were extracted from nine PCD-CT spectral datasets (40, 50, 70, 90, 110, 140, 180 keV, virtual non-contrast [VNC], and iodine density maps [IDM]) after nnU-Net segmentation confirmed by an abdominal radiologist, multiple machine-learning models were trained with lesion-level predictions aggregated per patient, and the Random Forest model trained on VNC achieved the highest performance (AUC 0.899; 95% CI 0.840-0.951; accuracy 83.5%), while cross-domain analysis showed similar mean AUCs across training reconstructions (0.75 to 0.83) and test reconstruction choice mattered: 110, 140, 180 keV and VNC were most stable (median AUC >= 0.

  3. Coronary calcium is detectable opportunistically on thoracic CT: pooled analyses show 52% prevalence, and AI models can automate scoring and predict cardiovascular death risk

    This review synthesizes evidence on opportunistically identifying and quantifying coronary artery calcium (CAC) on thoracic CT performed for other clinical indications (routine thoracic CT, lung cancer screening CT, attenuation correction CT), reporting a pooled CAC prevalence of 52%, independent associations with all-cause mortality (pooled relative risk 2.13) and major adverse cardiovascular events (pooled relative risk 2.61), and reviewing novel applications including AI/machine learning automated scoring, radiomics, photon-counting CT, and CAC as a multi-system biomarker, while noting that no randomized trials assessing the clinical impact of this approach have yet been published.

  4. Biparametric MRI Radiomics Combined with Serum Bone Turnover Biomarkers for Predicting Postoperative Bone Metastasis in Prostate Cancer: Precision Selection for Targeted Radionuclide Therapy

    In a prospective single-center cohort of 143 patients with clinically localized prostate cancer (cT1-2N0M0) undergoing laparoscopic radical prostatectomy, the study measured preoperative serum bone metabolism indicators such as osteocalcin N-terminal mid-fragment and alkaline phosphatase, extracted biparametric MRI radiomics variables including apparent diffusion coefficient mean and K trans mean, and integrated serum and imaging biomarkers with a multivariate logistic regression model; the integrated model reached an area under the ROC curve of 0.984, significantly outperforming individual biomarkers and imaging features (all p < 0.001), showed clinical net benefit with strong calibration (Hosmer-Lemeshow test p = 0.

  5. GPT-assisted radiomic modeling for predicting pathological complete response to neoadjuvant chemoimmunotherapy in head and neck squamous cell carcinoma

    In a training cohort (n = 186), a validation cohort (n = 116), and a prospective multicenter validation cohort (n = 269), this study extracted radiomic and supervised deep learning features from pretreatment T2-weighted MRI and compared manually developed with GPT-assisted modeling workflows, finding that fused features achieved the highest AUC for both manually developed and GPT-assisted logistic regression models (0.759 versus 0.763 ± 0.003 in the training cohort, 0.714 versus 0.741 ± 0.008 in the validation cohort, and 0.700 versus 0.706 ± 0.

  6. Recent Advances in Surveillance Strategies for Nasopharyngeal Carcinoma: From Guideline Follow-up to Individualized Precision Surveillance

    This review systematically examines current follow-up protocols and recent developments for nasopharyngeal carcinoma (NPC): on one hand it compares and analyzes major follow-up guidelines in terms of follow-up frequency, imaging modalities (MRI and PET), plasma EBV-DNA monitoring, and functional assessments; on the other hand it elaborates on the application prospects and research progress of genomics, radiomics, and artificial intelligence in NPC surveillance, noting that risk-stratified, individualized follow-up strategies such as those based on conditional survival models can enhance the cost-effectiveness of surveillance, while radiomics and artificial intelligence show promise for improving recurrence risk assessment, prognostic stratification, and individualized surveillance.

  7. The Evolving Role of Nuclear Medicine in Differentiating Pseudoprogression from Tumor Progression in Gliomas

    This review focuses on studies published over the past 18 months and examines the role of molecular PET imaging in differentiating treatment-related changes, especially pseudoprogression, from true tumor progression in gliomas, suggesting that static amino acid PET, particularly [18F]FET, may provide diagnostic information comparable to dynamic acquisition while simplifying protocols, that [68Ga]FAPI PET may add information on the tumor microenvironment, and that quantitative PET parameters are affected by reconstruction algorithms, reference regions and segmentation strategies, with artificial intelligence, radiomics and automated segmentation potentially improving the integration of multimodal and quantitative assessment.

  8. Radiomics and its application to neuro-oncology: A narrative review of advances, clinical application and implementation challenges

    This narrative review searched PubMed, Scopus and Web of Science (2012-2024) to map the role of radiomics and artificial intelligence in neuro-oncology across diagnostic, prognostic and therapeutic potential, reporting that radiomics can automatically extract quantitative features from MRI, CT and PET/CT that are not visible to the human eye, has been shown useful for pre-surgical classification of gliomas, survival prediction and differentiation between tumour progression and pseudo-progression, may improve diagnostic accuracy and support patient stratification by molecular biomarkers such as IDH and MGMT when integrated with deep learning, and links image phenotypes to genetic alterations through radiogenomics to enhance personalised medicine, while limitations persist from lack of proto

You’re all caught up